State of New Jersey Common Pension Fund D’s Crinetics Pharmaceuticals CRNX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.11M	Sell	29,624 -952	-3%	-$35.4K	﹤0.01%	1493
2026 Q1	$1.11M	Buy	30,576 +39	+0.1%	+$1.74K	﹤0.01%	1393
2025 Q4	$1.42M	Sell	30,537 -41,812	-58%	-$1.86M	0.01%	1379
2025 Q3	$3.01M	Buy	72,349 +9,797	+16%	+$313K	0.01%	768
2025 Q2	$1.8M	Buy	62,552 +6,674	+12%	+$206K	0.01%	1367
2025 Q1	$1.87M	Buy	55,878 +17,829	+47%	+$666K	0.01%	1109
2024 Q4	$1.95M	Buy	38,049 +708	+2%	+$39.6K	0.01%	1325
2024 Q3	$1.91M	Sell	37,341 -3,258	-8%	-$168K	0.01%	1388
2024 Q2	$1.82M	Sell	40,599 -31,501	-44%	-$1.45M	0.01%	1310
2024 Q1	$3.38M	Buy	+72,100	New	+$2.82M	0.01%	920

Other funds holding CRNX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jupiter Topco New York $245B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State of New Jersey Common Pension Fund D's CRNX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its Crinetics Pharmaceuticals (CRNX) stake by 3.1% in Q2 2026, selling an estimated $35.4K and leaving 29,624 shares worth $1.11M. The position accounts for ﹤0.01% of the portfolio, ranked #1493.

State of New Jersey Common Pension Fund D first reported a position in CRNX in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.38M in Q1 2024. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

State of New Jersey Common Pension Fund D held 29,624 shares of Crinetics Pharmaceuticals worth $1.11M as of Q2 2026.
State of New Jersey Common Pension Fund D sold 952 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $35.4K.
Crinetics Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1493 holding.
State of New Jersey Common Pension Fund D first reported a position in Crinetics Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
State of New Jersey Common Pension Fund D's Crinetics Pharmaceuticals position peaked at $3.38M in Q1 2024.
267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.